Prediction of sudden cardiac death in patients with chronic heart failure by regional washout rate in cardiac MIBG SPECT imaging.


Journal

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
ISSN: 1532-6551
Titre abrégé: J Nucl Cardiol
Pays: United States
ID NLM: 9423534

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 09 07 2016
accepted: 13 04 2017
pubmed: 14 5 2017
medline: 10 9 2020
entrez: 14 5 2017
Statut: ppublish

Résumé

The sympathetic nervous system provides an important trigger for major arrhythmic events through regional heterogeneity of sympathetic activity, which could be evaluated by SPECT imaging as the regional MIBG washout rate (WR). There is little information available on the prognostic value of regional WR in SPECT imaging for the prediction of sudden cardiac death (SCD) in patients with chronic heart failure (CHF). We studied 73 CHF outpatients with LVEF < 40%. At study entry, the regional WR was measured in 17 segments on the polar map. We defined abnormal regional WR as both the regional WR range (maximum - minimum regional WR) and maximum regional WR > mean value + 2SD obtained in 15 normal controls. During a mean follow-up of 7.5 ± 4.1 years, 15 of 73 patients had SCD. The abnormal regional WR and abnormal global WR on planar images were significantly and independently associated with SCD. Patients with both the abnormal regional WR and global WR had a significantly higher risk of SCD than those with none of these criteria. The analysis of regional MIBG WR on SPECT imaging provides additional prognostic value to global WR on planar images for SCD prediction in CHF patients.

Sections du résumé

BACKGROUND BACKGROUND
The sympathetic nervous system provides an important trigger for major arrhythmic events through regional heterogeneity of sympathetic activity, which could be evaluated by SPECT imaging as the regional MIBG washout rate (WR). There is little information available on the prognostic value of regional WR in SPECT imaging for the prediction of sudden cardiac death (SCD) in patients with chronic heart failure (CHF).
METHODS METHODS
We studied 73 CHF outpatients with LVEF < 40%. At study entry, the regional WR was measured in 17 segments on the polar map. We defined abnormal regional WR as both the regional WR range (maximum - minimum regional WR) and maximum regional WR > mean value + 2SD obtained in 15 normal controls.
RESULTS RESULTS
During a mean follow-up of 7.5 ± 4.1 years, 15 of 73 patients had SCD. The abnormal regional WR and abnormal global WR on planar images were significantly and independently associated with SCD. Patients with both the abnormal regional WR and global WR had a significantly higher risk of SCD than those with none of these criteria.
CONCLUSIONS CONCLUSIONS
The analysis of regional MIBG WR on SPECT imaging provides additional prognostic value to global WR on planar images for SCD prediction in CHF patients.

Identifiants

pubmed: 28500540
doi: 10.1007/s12350-017-0913-0
pii: 10.1007/s12350-017-0913-0
doi:

Substances chimiques

3-Iodobenzylguanidine 35MRW7B4AD
Norepinephrine X4W3ENH1CV

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109-117

Commentaires et corrections

Type : CommentIn

Références

Heart. 2001 Dec;86(6):656-60
pubmed: 11711461
J Am Coll Cardiol. 2003 Jan 15;41(2):231-8
pubmed: 12535815
Circ Res. 2004 Oct 15;95(8):754-63
pubmed: 15486322
J Nucl Med. 1992 Apr;33(4):471-7
pubmed: 1552326
Eur J Nucl Med Mol Imaging. 2005 Jun;32(6):682-8
pubmed: 15747157
Heart. 2007 Oct;93(10):1213-8
pubmed: 17344327
Circulation. 1991 Oct;84(4):1709-14
pubmed: 1914110
J Am Coll Cardiol. 2009 Feb 3;53(5):426-35
pubmed: 19179201
Circ Cardiovasc Imaging. 2008 Sep;1(2):131-40
pubmed: 19808530
J Am Coll Cardiol. 2010 May 18;55(20):2212-21
pubmed: 20188504
J Am Coll Cardiol. 2010 Jun 15;55(24):2769-77
pubmed: 20538172
Am J Cardiol. 2011 Apr 15;107(8):1185-90
pubmed: 21349482
Ann Nucl Med. 2011 Oct;25(8):571-9
pubmed: 21698436
J Nucl Cardiol. 2012 Feb;19(1):92-9
pubmed: 22147616
Eur Heart J. 2012 Jul;33(14):1787-847
pubmed: 22611136
Heart. 2012 Sep;98(18):1359-65
pubmed: 22904144
JACC Cardiovasc Imaging. 2013 Jul;6(7):772-84
pubmed: 23845574
Eur Heart J. 2014 Jul 1;35(25):1642-51
pubmed: 24801071
J Nucl Cardiol. 2014 Aug;21(4):756-62; quiz 753-55, 763-5
pubmed: 25015681
J Nucl Cardiol. 2016 Jun;23(3):425-35
pubmed: 25788403
Am J Cardiol. 2015 Jun 1;115(11):1549-54
pubmed: 25851796
J Nucl Med. 2015 Jun;56 Suppl 4:25S-30S
pubmed: 26033900
Am J Cardiol. 2016 Jun 15;117(12):1947-52
pubmed: 27237625
N Engl J Med. 1971 Dec 23;285(26):1441-6
pubmed: 5122894
N Engl J Med. 1984 Sep 27;311(13):819-23
pubmed: 6382011
Circulation. 1994 Feb;89(2):667-83
pubmed: 8313555
J Am Coll Cardiol. 1993 Oct;22(4 Suppl A):72A-84A
pubmed: 8376699
Nucl Med Commun. 1997 Mar;18(3):219-29
pubmed: 9106775
Eur J Nucl Med. 1997 May;24(5):523-9
pubmed: 9142733

Auteurs

Hironori Yamamoto (H)

Division of Cardiology, Osaka General Medical Center, 3-1-56, Mandai-Higashi, Sumiyoshi-ku, Osaka, 558-8558, Japan.

Takahisa Yamada (T)

Division of Cardiology, Osaka General Medical Center, 3-1-56, Mandai-Higashi, Sumiyoshi-ku, Osaka, 558-8558, Japan. takaymda@nike.eonet.ne.jp.

Shunsuke Tamaki (S)

Division of Cardiology, Osaka General Medical Center, 3-1-56, Mandai-Higashi, Sumiyoshi-ku, Osaka, 558-8558, Japan.

Takashi Morita (T)

Division of Cardiology, Osaka General Medical Center, 3-1-56, Mandai-Higashi, Sumiyoshi-ku, Osaka, 558-8558, Japan.

Yoshio Furukawa (Y)

Division of Cardiology, Osaka General Medical Center, 3-1-56, Mandai-Higashi, Sumiyoshi-ku, Osaka, 558-8558, Japan.

Yusuke Iwasaki (Y)

Division of Cardiology, Osaka General Medical Center, 3-1-56, Mandai-Higashi, Sumiyoshi-ku, Osaka, 558-8558, Japan.

Masato Kawasaki (M)

Division of Cardiology, Osaka General Medical Center, 3-1-56, Mandai-Higashi, Sumiyoshi-ku, Osaka, 558-8558, Japan.

Atsushi Kikuchi (A)

Division of Cardiology, Osaka General Medical Center, 3-1-56, Mandai-Higashi, Sumiyoshi-ku, Osaka, 558-8558, Japan.

Takumi Kondo (T)

Division of Cardiology, Osaka General Medical Center, 3-1-56, Mandai-Higashi, Sumiyoshi-ku, Osaka, 558-8558, Japan.

Tatsuhisa Ozaki (T)

Division of Cardiology, Osaka General Medical Center, 3-1-56, Mandai-Higashi, Sumiyoshi-ku, Osaka, 558-8558, Japan.

Masahiro Seo (M)

Division of Cardiology, Osaka General Medical Center, 3-1-56, Mandai-Higashi, Sumiyoshi-ku, Osaka, 558-8558, Japan.

Yoshihiro Sato (Y)

Division of Cardiology, Osaka General Medical Center, 3-1-56, Mandai-Higashi, Sumiyoshi-ku, Osaka, 558-8558, Japan.

Iyo Ikeda (I)

Division of Cardiology, Osaka General Medical Center, 3-1-56, Mandai-Higashi, Sumiyoshi-ku, Osaka, 558-8558, Japan.

Eiji Fukuhara (E)

Division of Cardiology, Osaka General Medical Center, 3-1-56, Mandai-Higashi, Sumiyoshi-ku, Osaka, 558-8558, Japan.

Makoto Abe (M)

Division of Cardiology, Osaka General Medical Center, 3-1-56, Mandai-Higashi, Sumiyoshi-ku, Osaka, 558-8558, Japan.

Jun Nakamura (J)

Division of Cardiology, Osaka General Medical Center, 3-1-56, Mandai-Higashi, Sumiyoshi-ku, Osaka, 558-8558, Japan.

Masatake Fukunami (M)

Division of Cardiology, Osaka General Medical Center, 3-1-56, Mandai-Higashi, Sumiyoshi-ku, Osaka, 558-8558, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH